E-Book Overview
Today, the integration of life insurance medicine into the framework of general medicine goes without saying. On the one hand, the diagnostic therapeutic knowledge of clinical medical science forms the tools of the insurance medical adviser for the evaluation of life insurance applications. On the other hand, life insurance medicine has been able to pro vide valuable statistical data for long-term prognosis which have become an essential part of the daily medical practice and prognostic appraisal. This mutual engagement and en richment has again distinctly manifested itself in the scientific program of the 13th Con gress of Life Assurance Medicine held in Madrid. Among the broad and varied data available, the insurance problem of cancer and ma lignant diseases of the haematopoietic system were extensively dealt with for the first time. Diagnostic therapeutic progress increasingly allows valuable insurance cover to be granted to formerly uninsurable risks, a group which is particularly in need of, and re quires, life insurance cover. The number of risks which are uninsurable becomes smaller and smaller.
E-Book Content
Annals of Life Insurance Medicine 6 Special Edition Proceedings of the 13th International Congress of Life Assurance Medicine Madrid 1979 Edited by E. Tanner and M. L. Hefti Sponsored by the Swiss Reinsurance Company Zurich/Switzerland
Springer-Verlag Berlin· Heidelberg· New York 1980
Professor E. TANNER, M. D. and M. L. HEITI, M. D., Swiss Reinsurance Company Mythenquai 50/60 CH-8022 Zurich/Switzerland
With 82 Figures
ISBN-13: 978-3-642-67631-4 e-ISBN-13: 978-3-642-67629-1 DOl: 10.1007/978-3-642-67629-1
This work is subject to copyright. All rights are reserved, whether the whole or parr of the material is concerned, specifically those of translation, reprinting, re-use of illustrations, broadcasting, reproduction
by photocopying machine of similar means, and storage in data banks. Under § 54 of the German Copy tight Law where copies are made for other than private use, a fee'is payable to the publisher, the amount of the fee to be determined by agreement with the publisher. t!'J by Springer.Verlag Berlin· Heidelberg 1980 Library ofCongtess Catalog Card Number 62·18597. Softcover reprint of the hardcover 1st edition 1980 The use of registered names, tradematks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free fat genetal use. Typesetting: Graphischer Betrieb Konrad Triltsch, H700 Wiirzburg. 2127/3130-543210
Preface Today, the integration of life insurance medicine into the framework of general medicine goes without saying. On the one hand, the diagnostic therapeutic knowledge of clinical medical science forms the tools of the insurance medical adviser for the evaluation of life insurance applications. On the other hand, life insurance medicine has been able to provide valuable statistical data for long-term prognosis which have become an essential part of the daily medical practice and prognostic appraisal. This mutual engagement and enrichment has again distinctly manifested itself in the scientific program of the 13th Congress of Life Assurance Medicine held in Madrid. Among the broad and varied data available, the insurance problem of cancer and malignant diseases of the haematopoietic system were extensively dealt with for the first time. Diagnostic therapeutic progress increasingly allows valuable insurance cover to be granted to formerly uninsurable risks, a group which is particularly in need of, and requires, life insurance cover. The number of risks which are uninsurable becomes smaller and smaller. The Annals of Life Insurance Medicine published by the Swiss Reinsurance Company in Zurich have as their m